POSTER SESSION II
Monday, March 3, 2008   —  1:00 PM - 4:30 PM
Convention Center, Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GENITOURINARY PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
107 Gleason Percent Pattern 4/5 Predicts Cancer-Specific Survival after Radical Prostatectomy (686)
L Cheng, DD Davidson, LQ Lin, MO Koch - Indiana University, Indianapolis, IN; Yale University, New Haven, CT 		Add
108 Correlation of Biopsy and Radical Prostatectomy Gleason Score in Contemporary Extended e"12 Core Biopsies Practice: Improved Correlation with Biopsy Worst Gleason Score (869)
AJ Wu, S Daignault, MJ Wasco, LP Kunju, JT Wei, DP Wood, RB Shah - University of Michigan Medical Center, Ann Arbor, MI 		Add
109 Gleason Grading of Prostatic Adenocarcinoma with Glomeruloid Features on Needle Biopsy (763)
TL Lotan, JI Epstein - Johns Hopkins Hospital, Baltimore, MD 		Add
110 The Border between Low- and High-Grade Gleason Score for Prostate Carcinoma: 6 or 7a (3+4)? (675)
A Billis, F Rogerio, RV Oliveira, AD Rodrigues, LLL Freitas, L Meirelles, LA Magna, U Ferreira - School of Medicine, State University of Campinas (Unicamp), Campinas, SP, Brazil 		Add
111 Grading of Infiltrating Cribriform Carcinoma on Prostate Needle Biopsy (753)
M Latour, MB Amin, A Billis, L Egevad, DJ Grignon, PA Humphrey, VE Reuter, W Sakr, JR Srigley, TM Wheeler, XJ Yang, JI Epstein - Johns Hopkins, Baltimore; Cedars Sinai, LA; Campinas, Sao Paulo, Brazil; IARC, Lyon, France; Indiana U., Indianapolis; Washington U., St. Louis; MSKCC, NY; Wayne State, Detroit; Credit Valley Hospital, Mississauga, Canada; Baylor, Houston; Cornell, NY 		Add
112 Any Proportion of Ductal Adenocarcinoma of the Prostate Predicts Higher Stage Disease (819)
H Samaratunga, B Delahunt, D Duffy, I Brown, J Yaxley - Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia; Wellington School of Medicine and Health Sciences, Wellington, Otago, New Zealand; Queensland Institute of Medical Research, Brisbane, Queensland, Australia; Royal Brisbane Hospital, Brisbane, Queensland, Australia 		Add
113 Significance of a New Entity Termed Diffuse Adenosis of the Prostatic Peripheral Zone (764)
TL Lotan, JI Epstein - Johns Hopkins Hospitals, Baltimore, MD 		Add
114 A Distinct Clinicopathological Entity - Autoimmune Pancreatitis-Associated Prostatitis (850)
T Uehara, H Hamano, M Kawakami, M Koyama, S Kawa, K Sano, T Honda, K Oki, H Ota - Shinshu University School of Medicine, Matsumoto, Japan; Shinshu University, Matsumoto, Japan; Shinshu University Hospital, Matsumoto, Japan; Komoro Kosei General Hospital, Komoro, Japan 		Add
115 Neoadjuvant Total Androgen Deprivation Produces a Characteristic Prostate Phenotype (846)
LD True, RB Montgomery, DW Lin, EA Mostaghel - University of Washington, Seattle 		Add
116 PSMA Expression in Schwannoma: Potential Diagnostic Pitfall for Metastatic Prostate Carcinoma by Radioimmunoscintigraphy Imaging Studies (862)
WL Wang, M Eisenberger, GJ Netto - Johns Hopkins University, Baltimore, MD 		Add
117 MALDI-MSI (Mass Spectometry Imaging) Discriminates Malignant and Nonmalignant Disease of the Prostate and Identifies Specific Protein Markers (680)
LH Cazares, SE Mendrinos, R Lance, MA Clements, RR Drake, OJ Semmes - Sentara Norfolk General Hospital and EVMS, Norfolk, VA; Eastern Virginia Medical School, Norfolk, VA 		Add
118 Distribution of FOXP3, CD4 and CD8 Positive Lymphocytic Cells in Benign and Malignant Prostatic Tissues (852)
A Valdman, S Jonmarker, R Rosenblatt, E Comperat, F Charlotte, M Roupert, P Pisa, L Egevad - Karolinska Institute, Stockholm, Sweden; La Pitie Salpetriere Hospital, Paris, France; International Agency for Research on Cancer, Lyon, France 		Add
119 Pathologic N-Stage, and Not Primary T-Stage Is a Significant Predictor of Relapse-Free Survival (RFS) in Bladder Cancer after Radical Cystectomy for Cancer: A Multivariate Cox Analysis in 247 Patients (857)
G Venkataraman, L Liu, S Masoom, F El-Salem, GP Paner, GA Barkan, DS Subramaniam, M Quek, RC Flanigan, EM Wojcik - Loyola University Medical Center, Maywood, IL; Evanston Northwestern Hospital, Evanston, IL; Lombardi Comprehensive Cancer Center, Georgetown, Washington, DC 		Add
120 Utility of a Combined Triple Immunohistochemical Stain Using CD44/CK20/p53 in the Diagnosis of Neoplastic and Non-Neoplastic Bladder Biopsies (691)
D Cimbaluk, S Bastacky, R Dhir, M Acquafondata, AV Parwani - University of Pittsburgh Medical Center, Pittsburgh, PA 		Add
121 Impact of Monopolar and Bipolar Electrocautery Thermal Artifact on the Pathologic Diagnosis of Transurethral Bladder Resection Specimens (725)
CF Haarer, A Gopalan, SW Fine, SK Tickoo, BH Bochner, VE Reuter - Memorial Sloan-Kettering Cancer Center, NY, NY 		Add
122 Small Endoscopic Biopsies of the Ureter and Renal Pelvis: Diagnostic Pitfalls (838)
F Tavora, T Lotan, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD 		Add
123 Secondary Intraurothelial Carcinoma and Muscle-Invasive Urothelial Carcinoma of the Bladder Shows Stem Cell-Like Features and Somatic Down-Regulation of DNA Mismatch Repair (817)
J Rubio, A Blanes, SJ Diaz-Cano - University of Malaga School of Medicine, Malaga, Spain; King's College Hospital, London, United Kingdom 		Add
124 Vascular Tumors & Tumor-Like Lesions of the Urinary Bladder (837)
F Tavora, E Montgomery, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD 		Add
125 Urethral Diverticula: A Clinicopathological Study of 50 Cases (729)
DE Hansel, AA Thomas, RR Rackley - The Cleveland Clinic, Cleveland, OH 		Add
126 Immunohistochemical Profile of Primary Urethral Carcinomas: Analysis of 60 Cases of Different Tumor Types (652)
AJ Adeniran, P Tamboli, BA Czerniak - The University of Texas M.D. Anderson Cancer Center, Houston, TX 		Add
127 Benign Nerve Sheath Tumors Involving the Urinary Bladder (859)
W Wang, E Montgomery, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD 		Add
128 Chromosomal Abnormalities Associated with Intestinal Metaplasia in the Urinary Bladder (783)
MJ Morton, S Zhang, A Lopez-Beltran, GT MacLennan, JN Eble, R Montironi, MT Sung, PH Tan, S Zheng, H Zhou, D Braitman, L Cheng - Indiana University, Indianapolis, IN; Cordoba University, Cordoba, Spain; Case Western Reserve University, Cleveland, OH; Polytechnic University of the Marche Region (Ancona), Ancona, Italy; Chang Gung Memorial Hospital-Kaohsiung Medical Center/Chang Gung University College of Medicine, Taiwan, Taiwan; Singapore General Hospital, Singapore, Singapore 		Add
129 Molecular Profiling of Transitional Cell Tumors of the Ovary and Bladder (701)
AB Domfeh, A Parwani, MN Nikiforova, GS Mantha, M Chivukula - Magee-Womens Hospital of UPMC, Pittsburgh, PA; UPMC, Pittsburgh, PA 		Add
130 The Spectrum of Histopathological Findings in Vesical Diverticulum (656)
MM Al-Khawaja, GT MacLennan, A Lopez-Beltran, R Montironi, L Cheng - Indiana University, Indianapolis, IN; Case Western Reserve University, Cleveland, OH; Cordoba University, Cordoba, Spain; Polytechnic University of the Marche Region (Ancona)/United Hospitals, Ancona, Italy 		Add
131 Synchronous Urinary Bladder and Prostate Cancer: A Retrospective Study (713)
P Gattuso, A Howard, VB Reddy, L Green - Rush University Medical Center, Chicago, IL; VA Hospital, Houston, TX 		Add
132 Lymphatic Vessel Density in Radical Prostatectomy Specimens Is Not a Prognostic Factor (685)
L Cheng, E Bishop, HH Zhou, GT MacLennan, A Lopez-Beltran, SB Zhang, S Badve, LA Baldridge, R Montironi - Indiana University, Indianapolis, IN; Case Western Reserve University, Cleveland, OH; Cordoba University, Cordoba, Spain; Polytechnic University of the Marche Region (Ancona)/United Hospitals, Ancona, Italy 		Add
133 Lymphatic Invasion in Pathologic Stage T3 Radical Prostatectomy Specimens as a Predictor of Biochemical Progression (788)
KB Mwamukonda, B Furusato, IA Sesterhenn, Y Chen, DG McLeod - Walter Reed Army Medical Center, Washington, DC; Armed Forces Institute of Pathology, Washington, DC; Center for Prostate Disease Research, Rockville, MD 		Add
134 Pathologic Findings in Men Undergoing Post-Treatment Biopsy "For Cause"after Primary Cryoablation for Prostate Cancer (823)
L Schoenfield, JS Jones, M Zhou, C Magi-Galluzzi - Cleveland Clinic, Cleveland 		Add
135 Residual Tumor Potentially Left Behind after Local Ablation Therapy in Prostate Adenocarcinoma (878)
GS Yoon, W Wang, AO Osunkoya, Z Lane, JI Epstein - The Johns Hopkins Hospital, Baltimore 		Add
136 Partial Atrophy on Prostate Needle Biposy Cores: A Morphological and Immunohistochemical Study (860)
W Wang, X Sun, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD; Lakewood Pathology Associates, Lakewood, NJ 		Add
137 Molecular Signature of Prostatic Atrophy (809)
M Powers, F Ozsolak, AL Salavaggione, MA Watson, PA Humphrey - Washington University School of Medicine, Saint Louis, MO 		Add
138 The Telomere Shortening in Prostatic Atrophy Lesions (738)
T Iwata, AK Meeker, E Smearman, AM De Marzo - Johns Hopkins University, Baltimore, MD; University of Maryland, Baltimore, MD 		Add
139 Improving Diagnosis of Renal Cell Carcinoma through Chromosome Copy Number Analysis with SNP Arrays (782)
FA Monzon, J Hagenkord, M Lyons-Weiler, CM Sciulli, U Chandran, A Lisovitch, R Dhir, JM Gonzalez-Berjon, AV Parwani - The Methodist Hospital, Houston, TX; University of Pittsburgh, Pittsburgh, PA 		Add
140 Gene Expression Profiling Designs TFE/MiTF Renal Cell Translocation Carcinomas As a Distinct Group among Renal Cell Carcinomas (678)
P Camparo, E Comperat, Y Denoux, C Dykema, K Furge, V Molinie, M Sibony, V Vasiliu, A Vieillefond, BT Teh - HIA Val de Grace, Paris, France; CHU est UMPC Paris 6, Paris, France; Hopital Foch, Suresnes, France; Van Andel Research Institute, Grand Rapids, MI; Hopital Necker, Paris, France; Hopital Cochin, Paris, France 		Add
141 The Incidence of TFE3 Translocation Renal Carcinoma among Adult Patients (733)
B Higa, RC Flanigan, MM Picken - Loyola University Medical Center, Maywood 		Add
142 Proteomic Analysis Identifies Key Metabolic and Stress Proteins Differentially Expressed in Renal Cell Carcinomas (853)
VA Valera, D Roberts, WM Linehan, MJ Merino - National Cancer Institute, Bethesda, MD 		Add
143 Hypoxia Inducible Factor (HIF) Pathway in Papillary Renal Cell Carcinoma: A Tissue Microarray Based Immunohistochemical (IHC) Study (815)
SM Rohan, HA Al-Ahmadie, SW Fine, A Gopalan, ME Dudas, VE Reuter, SK Tickoo - Memorial Sloan Kettering Cancer Center, NY, NY 		Add
144 Topoisomerase IIa Expression in Renal Medullary Carcinoma: Potential Diagnostic and Therapeutic Implications (858)
W Wang, E Schaeffer, NA Brownlee, P Argani, JI Epstein, A Toubaji, A Billis, CP Pavlovich, GJ Netto - Johns Hopkins University, Baltimore, MD; State University of Campinas, Sao Paolo, Brazil 		Add
145 A Useful Panel of Immunohistochemical Markers in Differentiating Papillary Renal Cell Carcinoma from Papillary Urothelial Carcinoma (756)
F Lin, J Shi, XJ Yang, PL Zhang, W Dupree - Geisinger Medical Center, Danville, PA; Cornell University, New York, NY 		Add
146 Immunohistochemical (IHC) Panel for Subtype Classification of Renal Neoplasms (755)
F Liang, M Chivukula, AV Parwani, MB Acquafondata, R Dhir - University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA 		Add
147 PAX8: An Additional Marker for Kidney Tumors (880)
WM Yu, D Hamele-Bena, L Memeo, M Mansukhani, G-X Tong - Columbia University Medical Center, New York, NY 		Add